PURPOSE
Discharge planning following brain tumor resection is often variable, contributing to delays in care coordination after discharge. While structured discharge prediction tools are widely used in orthopedic and spine surgery, no standardized preoperative framework exists in neurosurgical oncology. We conducted an...
Samuel Latzman, Shoaib A. Syed, Griffin Thomas et al.· Journal of clinical neurosci...· 0 citations
O^6^-methylguanine–DNA methyltransferase (MGMT) promoter methylation is a key predictive biomarker for temozolomide (TMZ) response in glioma. MGMT status is routinely assessed at diagnosis; however, its utility at recurrence remains incompletely characterized. We aimed to quantify MGMT methylation stability and assess...
H. Noren, Gabriella Pelofsky, Brianna Suffren et al.· Journal of Neuro-Oncology· 0 citations
Routine ASM prophylaxis in seizure-naïve patients undergoing intracranial tumor resection is not supported by current evidence or clinical guidelines, and a selective, risk-based approach with short-term prophylaxis may be considered in patients with high-risk features.
N. Seenarine, Samuel Latzman, Laura Mittelman et al.· Current Neurology and Neuros...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.